Article
A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma.
Blood
(2001)
Disciplines
Publication Date
April 1, 2001
DOI
10.1182/blood.V97.7.1942
Citation Information
John E. Janik, Langdon L. Miller, Edward L. Korn, Diane Stevens, et al.. "A prospective randomized phase II trial of GM-CSF priming to prevent topotecan-induced neutropenia in chemotherapy-naive patients with malignant melanoma or renal cell carcinoma." Blood Vol. 97 Iss. 7 (2001) p. 1942 - 1946 Available at: http://works.bepress.com/walter-urba/228/